Item Type | Name |
Concept
|
Cisplatin
|
Academic Article
|
Collagen matrix cisplatin prevents local tumor growth after margin-positive resection.
|
Academic Article
|
Axial ligands and alicyclic ring size modulate the activity and biochemical pharmacology of ammine/cycloalkylamine-platinum(IV) complexes in tumor cells resistant to cis-diamminedichloroplatinum(II) or trans-1R,2R-1S,2S-diaminocyclohexanetetrachloroplatinum(IV).
|
Academic Article
|
Modulation of cytotoxicity and cellular pharmacology of 1,2-diaminocyclohexane platinum (IV) complexes mediated by axial and equatorial ligands.
|
Academic Article
|
Effect of whole body hyperthermia on cis-diamminedichloroplatinum (II)-induced antitumour activity and tissue Pt-distribution: do anaesthetics influence the therapeutic ratio?
|
Academic Article
|
Cytotoxicity and tolerance to DNA adducts of alicyclic mixed amine platinum(II) homologs in tumor models sensitive and resistant to cisplatin or tetraplatin.
|
Academic Article
|
Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
|
Academic Article
|
Model platinum nucleobase and nucleoside complexes and antitumor activity: X-ray crystal structure of [PtIV(trans-1R,2R-diaminocyclohexane)trans-(acetate)2(9-ethylguanine)Cl]NO3.H2O.
|
Academic Article
|
The impact of S- and G2-checkpoint response on the fidelity of G1-arrest by cisplatin and its comparison to a non-cross-resistant platinum(IV) analog.
|
Academic Article
|
Pharmacokinetics of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II) and cisplatin given i.v. and i.p. in the rat.
|
Academic Article
|
Effect of carboplatin combined with whole body hyperthermia on normal tissue and tumor in rats.
|
Academic Article
|
Extracorporeal hemofiltration: a model for decreasing systemic drug exposure with intra-arterial chemotherapy.
|
Academic Article
|
Increased therapeutic gain of combined cis-diamminedichloroplatinum (II) and whole body hyperthermia therapy by optimal heat/drug scheduling.
|
Academic Article
|
Organ distribution and tumor uptake of liposome entrapped cis-bis-neodecanoato trans-R, R-1,2 diaminocyclohexane platinum (II) administered intravenously and into the proper hepatic artery.
|
Academic Article
|
Haematological toxicity of carboplatin in rats.
|
Academic Article
|
Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
|
Academic Article
|
Distinct P-glycoprotein expression in two subclones simultaneously selected from a human colon carcinoma cell line by cis-diamminedichloroplatinum (II).
|
Academic Article
|
Modulatory effect of axial and equatorial ligands on antitumor activities of trans-1R,2R-diaminocyclohexane platinum(IV) complexes.
|
Academic Article
|
Haematological toxicity of carboplatin and cisplatin combined with whole body hyperthermia in rats.
|
Academic Article
|
Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
|
Academic Article
|
Expression of p53 in cisplatin-resistant ovarian cancer cell lines: modulation with the novel platinum analogue (1R, 2R-diaminocyclohexane)(trans-diacetato)(dichloro)-platinum(IV).
|
Academic Article
|
Preparation, characterization, and antitumor activity of new cisplatin analogs with homopiperazines: crystal structure of [PtII(1-methylhomopiperazine)(methylmalonato)].2H2O.
|
Academic Article
|
Bimodal effects of 1R,2R-diaminocyclohexane(trans-diacetato)(dichloro)platinum(IV) on cell cycle checkpoints.
|
Academic Article
|
Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells.
|
Academic Article
|
Increased sensitivity of a metastatic model of prostate cancer to a novel tetravalent platinum analog.
|
Academic Article
|
Therapeutic Targeting of ATP7B in Ovarian Carcinoma.
|
Academic Article
|
Protein kinase inhibitors emodin and dichloro-ribofuranosylbenzimidazole modulate the cellular accumulation and cytotoxicity of cisplatin in a schedule-dependent manner.
|
Academic Article
|
Tissue platinum concentration and tumor response in non-small-cell lung cancer.
|
Academic Article
|
ATP11B mediates platinum resistance in ovarian cancer.
|
Academic Article
|
Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy.
|
Academic Article
|
Preparation, characterization, and antitumor activity of water-soluble aminoalkanol platinum(II) complexes.
|
Academic Article
|
A comparison of thermal enhancement of cis-diamminedichloroplatinum (II) induced renal and intestinal toxicities by whole body hyperthermia in the rat.
|
Academic Article
|
The effect of diethyldithiocarbamate on the haematological toxicity and antitumour activity of carboplatin.
|
Academic Article
|
Comparative distribution and excretion of carboplatin and cisplatin in mice.
|
Academic Article
|
The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
|
Academic Article
|
o-(beta-Hydroxyethyl)-rutoside-mediated protection of renal injury associated with cis-diamminedichloroplatinum(II)/hyperthermia treatment.
|
Academic Article
|
Mesna does not reduce cisplatin induced nephrotoxicity in the rat.
|
Academic Article
|
Stimulation of microsomal drug oxidation in liver and kidney of rats treated with the oncolytic agent cis-dichlorodiammineplatinum-II.
|
Academic Article
|
Alterations in hepatic and renal levels of glutathione and activities of glutathione S-transferase from rats treated with cis-dichlorodiammineplatinum-II.
|
Academic Article
|
Circumvention of platinum resistance: structure-activity relationship for homologous series of ammine/amine platinum(II) complexes in L1210 cell lines.
|
Academic Article
|
Kinetics of tissue disposition of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin in mice bearing FSaIIC tumors.
|
Academic Article
|
Correlation of total and interstrand DNA adducts in tumor and kidney with antitumor efficacies and differential nephrotoxicities of cis-ammine/cyclohexylamine-dichloroplatinum(II) and cisplatin.
|
Academic Article
|
Synthesis and antitumor activity of 1,2-diaminocyclohexane platinum(IV) complexes.
|
Academic Article
|
Synthesis, characterization, and antitumor activity of a series of novel cisplatin analogs with cis-1,4-diaminocyclohexane as nonleaving amine group.
|
Academic Article
|
Chemical and biological studies on a series of novel (trans-(1R,2R)-, trans-(1S,2S)-, and cis-1,2-diaminocyclohexane)platinum(IV) carboxylate complexes.
|
Academic Article
|
Independent pathways of p53 induction by cisplatin and X-rays in a cisplatin-resistant ovarian tumor cell line.
|
Academic Article
|
Role of p53 in the ability of 1,2-diaminocyclohexane-diacetato-dichloro-Pt(IV) to circumvent cisplatin resistance.
|
Academic Article
|
Overexpression of edg-2/vzg-1 induces apoptosis and anoikis in ovarian cancer cells in a lysophosphatidic acid-independent manner.
|
Academic Article
|
EGF receptor and p21WAF1 expression are reciprocally altered as ME-180 cervical carcinoma cells progress from high to low cisplatin sensitivity.
|
Academic Article
|
Synthesis, characterization and cytotoxicity of new platinum(IV) axial carboxylate complexes: crystal structure of potential antitumor agent [PtIV(trans-1R,2R-diaminocyclohexane)trans(acetate)2Cl2].
|
Academic Article
|
Cisplatin: mode of cytotoxic action and molecular basis of resistance.
|
Academic Article
|
Role of human copper transporter Ctr1 in the transport of platinum-based antitumor agents in cisplatin-sensitive and cisplatin-resistant cells.
|
Academic Article
|
Upregulation of p27 and its inhibition of CDK2/cyclin E activity following DNA damage by a novel platinum agent are dependent on the expression of p21.
|
Academic Article
|
Elevated glutathione levels confer cellular sensitization to cisplatin toxicity by up-regulation of copper transporter hCtr1.
|
Academic Article
|
Increased therapeutic efficacy induced by tumor necrosis factor alpha combined with platinum complexes and whole-body hyperthermia in rats.
|
Academic Article
|
Chronic effect of whole-body hyperthermia combined simultaneously with cis-diamminedichloroplatinum (II) on normal tissue in rat.
|
Academic Article
|
Ammine/amine platinum (II) complexes effective in vivo against murine tumors sensitive or resistant to cisplatin and tetraplatin.
|
Academic Article
|
Biochemical pharmacology of homologous alicyclic mixed amine platinum(II) complexes in sensitive and resistant tumor cell lines.
|
Academic Article
|
Preparation, characterization, and antitumor activity of new cisplatin analogues with 1-methyl-4-(methylamino)piperidine: crystal structure of [PtII(1-methyl-4-(methylamino) piperidine)(oxalate)].
|
Academic Article
|
The effects of anaesthetics on cisplatinum-induced toxicity at normal temperatures and during whole-body hyperthermia: the influence of NaCl concentration of the vehicle.
|
Academic Article
|
Thermal enhancement of drug uptake and DNA adducts as a possible mechanism for the effect of sequencing hyperthermia on cisplatin-induced cytotoxicity in L1210 cells.
|
Academic Article
|
Biochemical and molecular mechanisms of cisplatin resistance.
|
Academic Article
|
Biologic effects of dopamine on tumor vasculature in ovarian carcinoma.
|
Academic Article
|
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer.
|
Academic Article
|
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells
|
Academic Article
|
Direct intratumoral injection of a novel collagen matrix gel and cisplatin effectively controls experimental liver tumors
|
Academic Article
|
New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status
|
Academic Article
|
Heterozygous p53V172F mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53
|
Academic Article
|
Modulation of the haematological, renal and gastrointestinal toxicities of cisplatin and carboplatin when administered via the oral route in rodents
|
Academic Article
|
A texaphyrin-oxaliplatin conjugate that overcomes both pharmacologic and molecular mechanisms of cisplatin resistance in cancer cells.
|
Academic Article
|
Heterozygous p53(V172F) mutation in cisplatin-resistant human tumor cells promotes MDM4 recruitment and decreases stability and transactivity of p53.
|
Academic Article
|
New bipyridine gold(III) dithiocarbamate-containing complexes exerted a potent anticancer activity against cisplatin-resistant cancer cells independent of p53 status.
|
Academic Article
|
Functional Activation of Mutant p53 by Platinum Analogues in Cisplatin-Resistant Cells Is Dependent on Phosphorylation.
|
Academic Article
|
Drug-dependent functionalization of wild-type and mutant p53 in cisplatin-resistant human ovarian tumor cells.
|
Academic Article
|
PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis.
|
Academic Article
|
Cisplatin in Combination with MDM2 Inhibition Downregulates Rad51 Recombinase in a Bimodal Manner to Inhibit Homologous Recombination and Augment Tumor Cell Kill.
|
Academic Article
|
Protein expression profiling identifies differential modulation of homologous recombination by platinum-based antitumor agents.
|
Academic Article
|
Oncolytic HSV Therapy Modulates Vesicular Trafficking Inducing Cisplatin Sensitivity and Antitumor Immunity.
|
Academic Article
|
Corrigendum to "PTGER3 induces ovary tumorigenesis and confers resistance to cisplatin therapy through up-regulation Ras-MAPK/Erk-ETS1-ELK1/CFTR1 axis" [EBioMedicine 40 (2019) 290-304].
|